REGiMMUNE Completes $9.2 Million Series D Financing
Tokyo, Japan – February 14, 2014 – REGiMMUNE Corporation announced [...]
Tokyo, Japan – February 14, 2014 – REGiMMUNE Corporation announced [...]
REGiMMUNE Completes $9.2 Million Series D Financing Tokyo, Japan – [...]
Positive Phase I Clinical Trial Supports Initiation of Phase II [...]
REGiMMUNE Begins Enrollment for Phase II Clinical Trial for Graft [...]
REGiMMUNE Corporation relocated its US offices from Santa Clara to [...]
Tokyo, Japan., Dec 26, 2013 – REGiMMUNE Corporation (RGI) today announced [...]
Tokyo, Japan., Dec 26, 2013 – REGiMMUNE Corporation (RGI) today announced [...]
Santa Clara, CA and TOKYO — April 12, 2013 — [...]
RGI-2001 has been granted Orphan Drug Designation for RGI-2001 from [...]
Tokyo, Japan-(OCT. 28, 2012) – REGiMMUNE Corporation announced today that [...]